[1]
Wichrowska, M., Kocięcki , J. and Suda, W. 2021. Switching between aflibercept and ranibizumab in the treatment of refractory exudative age-related macular degeneration. OphthaTherapy. Therapies in Ophthalmology. 8, 3 (Aug. 2021), 167-173. DOI:https://doi.org/10.24292/01.OT.270821.